RECOVERY: A Transdiagnostic Intervention for Anxiety and Depression

Depression Clinical Trial

— RECOVERY  

Official title:

RECOVERY: An Internet-delivered Transdiagnostic Cognitive Behavior Therapy in Romania

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03917550
• Other study ID #: WUT - RECOVERY
• Status: Recruiting
• Phase: N/A
• Start date: March 18, 2019
• Est. completion date: March 27, 2020

Study information

• Verified date: April 2019
• Source: West University of Timisoara
• Contact: Bogdan Tudor Tulbure, PhD
• Phone: 0040745753061
• Email: btulbure[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To investigate the efficacy and acceptability of a guided internet delivered transdiagnostic intervention, targeting mild to moderate clinical symptoms of anxiety and depression and emphasizing the changes taking place at the level of the structures of the self.

Description:

The effectiveness of a Transdiagnostic Cognitive-Behavioral Treatment will be compared with an improved version of it, in which new intervention techniques were added, pointing out the importance of improving some self-concept dimensions in reducing symptoms of anxiety and depression. In order to prove this, the study design will include two active intervention groups; a standard transdiagnostic intervention protocol will be delivered to one group and an improved version of the same transdiagnostic protocol will be delivered to the other group. The new added techniques targets some self-concepts, namely self-compassion, unconditional self-acceptance and self-esteem. The main goal of the study is to concurrently test effectiveness of these two transdiagnostic approaches in reducing symptoms of anxiety and depression and improving the above-mentioned self-concepts. This non-inferiority trial has the power to detect an effect size larger than Cohen's d = .40 (including 20% attrition at post-test and 6 month follow-up)

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 260
• Est. completion date: March 27, 2020
• Est. primary completion date: August 30, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. be fluent in Romanian,

2. be at least 18 years of age,

3. have at least a clinical diagnosis of major depressive disorder/dysthymia, and/or generalized anxiety disorder, and/or social anxiety disorder, panic anxiety disorder and/or Agoraphobia, specific phobia or any combination of these conditions on Structured Clinical Interview for the Diagnostic and Statistical Manual for Mental Disorders 5 (SCID-I 5)

Exclusion Criteria:

1. suicidal plans,

2. changes in the dosage if psychotropic medication during the last month (if present),

3. have bipolar disorder or psychosis (according to medication status),

4. have an alcohol/substance abuse and/or dependence disorder,

5. currently take part in other psychological treatment,

6. obvious obstacle to participation (i.e., no current Internet access, long travel plans during the treatment period etc.)

Related Conditions & MeSH terms

• Anxiety Disorders
• Depression
• Depressive Disorder
• Disease
• Dysthymic Disorder
• Generalized Anxiety Disorder
• Panic Disorder
• Phobia, Social
• Phobic Disorders
• Social Phobia
• Specific Phobia

Intervention

Behavioral:
• Recovery (Transdiagnostic & self)
This transdiagnostic program is based on the general Cognitive Behavioral Therapy (CBT) principles and targets core higher order factors such as negative affectivity and emotion dysregulation, using common intervention techniques applicable across disorders. The program was designed to directly address the aversive emotional experiences often reported by clients, hoping to reverse participants' maladaptive thinking style and dysfunctional behaviors. In addition, specific intervention designed to improve self-compassion, unconditional self-acceptance, self-esteem and self concept clarity were added.
• Transdiagnostic
This transdiagnostic program is based on the general Cognitive Behavioral Therapy (CBT) principles and targets core higher order factors such as negative affectivity and emotion dysregulation, using common intervention techniques applicable across disorders. The program was designed to directly address the aversive emotional experiences often reported by clients, hoping to reverse participants' maladaptive thinking style and dysfunctional behaviors.

Locations

Country	Name	City	State
Romania	West University of Timisoara	Timi?oara	Timi?

Sponsors (1)

Lead Sponsor	Collaborator
West University of Timisoara

Country where clinical trial is conducted

Romania, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Patient Health Questionnaire 9 (PHQ9)	The Patient Health Questionnaire 9 (PHQ9) was designed to measure participant's level of depression. The scale is unidimensional and the total score ranges from 0 to 27. Low scores are associated with low levels of depression, while high scores are associated with high levels of depression.	Absolute values (average score) of PHQ9 at 10 weeks (post-intervention)
Primary	Generalized Anxiety Disorder 7 (GAD7)	Generalized Anxiety Disorder 7 (GAD7) was designed to measure participant's level of generalized anxiety or worry. The scale is unidimensional and the total score ranges from 0 to 21. Low scores are associated with low levels of worry, while high scores are associated with high levels of worry.	Absolute values (average score) of GAD7 at 10 weeks (post-intervention)
Primary	Social Phobia Inventory (SPIN)	The SPIN was designed to measure participant's level of social phobia. The scale is unidimensional and the total score ranges from 0 to 68. Low scores are associated with low levels of social phobia, while high scores are associated with high levels of social phobia.	Absolute values (average score) of SPIN at 10 weeks (post-intervention)
Primary	Panic Disorder Severity Scale-Self Report (PDSS-SR)	The PDSS-SR was designed to measure participant's level of panic. The scale is unidimensional and the total score rages from 0 to 28. Low scores are associated with low levels of panic, while high scores are associated with high levels of panic.	Absolute values (average score) of PDSS-SR at 10 weeks (post-intervention)
Secondary	Work and Social Adjustment Scale (WSAS)	Work and Social Adjustment Scale (WSAS) was designed to measure symptom interference. The scale is unidimensional and the total score ranges from 0 to 40. Low scores are associated with higher levels of functioning (less interference of clinical symptoms) while high scores are associated with lower levels of functioning (or high interference of clinical symptoms).	Absolute values (average score) of WSAS at 10 weeks (post-intervention)
Secondary	Beck Depression Inventory-II (BDI-II)	The Beck Depression Inventory-II (BDI-II) was designed to measure participant's level of depression. The scale is unidimensional and the total score ranges from 0 to 63. Low scores are associated with low levels of depression, while high scores are associated with high levels of depression.	Absolute values (average score) of BDI-II at 10 weeks (post-intervention)
Secondary	Penn State Worry Questionnaire (PSWQ)	The PSWQ was designed to measure participant's level of generalized anxiety or worry. The scale is unidimensional and the total score ranges from 16 to 80. Low scores are associated with low levels of worry, while high scores are associated with high levels of worry.	Absolute values (average score) of PSWQ at 10 weeks (post-intervention)
Secondary	Anxiety Sensitivity Index 16 (ASI16)	The ASI was designed to measure participant's level of anxiety sensitivity. The scale is unidimensional and the total score rages from 0 to 64. Low scores are associated with low levels of anxiety sensitivity, while high scores are associated with high levels of anxiety sensitivity.	Absolute values (average score) of ASI at 10 weeks (post-intervention)
Secondary	Self-Concept Clarity Scale (SCCS)	SCCS was designed to measure participant's level of their Self-Concept Clarity. The scale is unidimensional and the total score rages from 12 to 60. Low scores are associated with low levels of Self-Clarity, while high scores are associated with high levels of Self-Clarity.	Absolute values (average score) of SCCS at 10 weeks (post-intervention)
Secondary	New General Self-Efficacy Scale (NGSE)	NGSE was designed to measure participant's level of Self-Efficacy. The scale is unidimensional and the total score rages from 8 to 40. Low scores are associated with low levels of Self-Efficacy, while high scores are associated with high levels of Self-Efficacy.	Absolute values (average score) of NGSE at 10 weeks (post-intervention)
Secondary	Unconditional Self-Acceptance Questionnaire (USAQ)	USAQ was designed to measure participant's level of unconditional Self-Acceptance. The scale is unidimensional and the total score rages from 20 to 140. Low scores are associated with low levels of unconditional Self-Acceptance, while high scores are associated with high levels of unconditional Self-Acceptance.	Absolute values (average score) of USAQ at 10 weeks (post-intervention)
Secondary	Overall Anxiety Severity and Impairment Scale (OASIS)	The OASIS was designed to measure participant's level of overall anxiety level. The scale is unidimensional and the total score rages from 0 to 20. Low scores are associated with low levels of anxiety, while high scores are associated with high levels of anxiety.	Absolute values (average score) of OASIS at 10 weeks (post-intervention)
Secondary	Overall Depression Severity and Impairment Scale (ODSIS)	The ODSIS was designed to measure participant's level of overall depression level. The scale is unidimensional and the total score rages from 0 to 20. Low scores are associated with low levels of depression, while high scores are associated with high levels of depression.	Absolute values (average score) of ODSIS at 10 weeks (post-intervention)
Secondary	Rosenberg Self-Esteem Scale (RSES)	Rosenberg Self-Esteem Scale was designed to measure participant's level of Self-Esteem. The scale is unidimensional and the total score rages from 10 to 40. Low scores are associated with low levels of Self-Esteem, while high scores are associated with high levels of Self-Esteem.	Absolute values (average score) of RSES at 10 weeks (post-intervention)
Secondary	Self-Compassion Scale (SCS)	SCS was designed to measure participant's level of their Self-Compassion. The scale is multidimensional and the total score rages from 26 to 130. Low scores are associated with low levels of Self-Compassion, while high scores are associated with high levels of Self-Compassion.	Absolute values (average score) of SCS at 10 weeks (post-intervention)
Secondary	Minnesota Multiphasic Personality Inventory 2 Neagtive Treatment Indicator Scale (MMPI2TRT)	MMPI2TRT was designed to measure participants negative attitudes toward doctors/mental health professionals and unwilling to discuss personal problems. The scale is unidimensional and the total score rages from 0 to 26. Low scores are associated positive attitudes towards doctors and willingness to discuss problems while high scores are associated with negative attitudes toward doctors and unwilling to discuss personal problems.	Absolute values (average score) of MMPI2TRT at 10 weeks (post-intervention)
Secondary	Personality Clinical Form - Neagtive TReaTment Indicator Scale (PCFTRT)	PCFTRT is a new subscale designed to assess participants negative attitudes toward mental health professionals and unwilling to discuss personal problems. The subscale is unidimensional and the total score rages from 0 to 24. Low scores are associated positive attitudes towards doctors and willingness to discuss problems while high scores are associated with negative attitudes toward doctors and unwilling to discuss personal problems.	Absolute values (average score) of PCFTRT at 10 weeks (post-intervention)

External Links

•   Project official website